Search results
Sanofi reaches agreement with Novavax regarding COVID-19 vaccine
WFMZ Eastern Pennsylvania and Western New Jersey· 9 hours agoThe agreement involves co-commercializing the COVID-19 vaccine, developing novel COVID-19-Influenza...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 9 hours ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And...
Benzinga via Yahoo Finance· 16 hours agoThe terms of the agreement include: A co-exclusive license to co-commercialize Novavax’s current...
Novavax, Sanofi Ink Deal to Commercialize COVID-19 Vaccine to Jointly Produce Combination Shots -...
EconoTimes· 20 hours agoNovavax, Inc., a biotechnology company headquartered in Gaithersburg, Maryland, revealed on Friday,...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 15 hours ago(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing...
France’s Sanofi in COVID-19 vaccine deal with Novavax
WSAU Wausau· 23 hours agoPARIS (Reuters) - Sanofi on Friday announced it has reached a licensing agreement with Novavax to...
Novavax Stock Doubles on $1.2B Sanofi Deal for COVID-19, Flu Vaccines
Investopedia· 23 hours agoNovavax (NVAX) shares more than doubled in intraday trading Friday after announcing a $1.2 billion...
French, US drug firms team up for Covid-flu shot
AFP via Yahoo Finance· 19 hours agoFrench pharmaceutical giant Sanofi and struggling US rival Novavax announced Friday an alliance to sell a Covid vaccine and develop another ...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 12 hours agoDriving the news: Novavax will receive an upfront payment of $500 million and up to $700 million in...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 16 hours agoNovavax announced a $1.2 billion licensing partnership with French pharmaceutical company Sanofi on...